IMTX (Immatics NV) OCF Margin %: -552.33% (As of Mar. 2026)

What is Immatics NV OCF Margin %?

Immatics NV IMTX -2.84% 60 OCF Margin % is -552.33% as of Mar. 2026. GuruFocus rates IMTX with a GF Score™ of 60/100 and a GF Value™ of $3.57 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 960 Biotechnology companies, Immatics NV ranks worse than 72.92% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Immatics NV's Cash Flow from Operations for the three months ended in Mar. 2026 was $-48.61 Mil. Immatics NV's Revenue for the three months ended in Mar. 2026 was $8.80 Mil. Therefore, Immatics NV's OCF Margin % for the quarter that ended in Mar. 2026 was -552.33%.

As of today, Immatics NV's current OCF Yield % is -16.14%.

The historical rank and industry rank for Immatics NV's OCF Margin % or its related term are showing as below:

IMTX' s OCF Margin % Range Over the Past 10 Years
Min: -365.94 Med: -33.83 Max: 548.64
Current: -493.92

During the past 8 years, the highest OCF Margin % of Immatics NV was 548.64%. The lowest was -365.94%. And the median was -33.83%.

IMTX's OCF Margin % is ranked worse than
72.92% of 960 companies
in the Biotechnology industry
Industry Median: -68.59 vs IMTX: -493.92

Immatics NV OCF Margin % Related Terms

Immatics NV OCF Margin % Historical Data

* Premium members only.

The historical data trend for Immatics NV's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immatics NV OCF Margin % Chart

Immatics NV Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

OCF Margin %

Get a 7-Day Free Trial

-243.78

57.94

33.76

-101.41

-365.94

Immatics NV Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
OCF Margin %	Get a 7-Day Free Trial															-184.08	-824.41	-861.78	-296.88	-552.33

IMTX vs INVA, PGEN, VIR: OCF Margin % Comparison

For the Biotechnology subindustry, Immatics NV's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immatics NV OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immatics NV's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Immatics NV's OCF Margin % falls into.

Save Embed

60GF Score

Immatics NV IMTX

OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Immatics NV OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Immatics NV's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin	=	Cash Flow from Operations (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-206.822	/	56.518
	=	-365.94 %

Immatics NV's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin	=	Cash Flow from Operations (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-48.605	/	8.8
	=	-552.33 %

Frequently Asked Questions Learn more about OCF Margin % →

What does a OCF Margin % of -552.33% mean?

Immatics NV (IMTX) has a OCF Margin % of -552.33% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Immatics NV and its competitors. According to the industry distribution chart, Immatics NV ranks #700 out of 960 companies in the Biotechnology industry, placing it in the top 72.9%.

Is Immatics NV's OCF Margin % too high?

Immatics NV's current OCF Margin % is -552.33%. Based on the distribution chart, Immatics NV ranks #700 out of 960 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Immatics NV has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Immatics NV's OCF Margin % compare to INVA and PGEN?

According to the Biotechnology industry distribution chart, Immatics NV ranks #700 out of 960 companies for OCF Margin %. This places Immatics NV in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good OCF Margin % for a Biotechnology company?

A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high OCF Margin % mean?

A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Immatics NV and its competitors. Immatics NV's current OCF Margin % is -552.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Immatics NV stock overvalued right now?

Based on GuruFocus' analysis, Immatics NV (IMTX) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.57, compared to a current price of $9.74 — trading 172.7% above its estimated fair value. The current OCF Margin % is -552.33%. Immatics NV's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is OCF Margin % calculated?

OCF Margin % is calculated from a company's financial statements. For Immatics NV (IMTX), the current OCF Margin % is -552.33% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Immatics NV (IMTX) Overvalued in 2026?

Based on GuruFocus' analysis, Immatics NV stock appears to be overvalued. The current stock price of $9.74 is trading 172.7% above its estimated GF Value™ of $3.57. GuruFocus considers Immatics NV to be Significantly Overvalued.

Key valuation signals for IMTX:

OCF Margin %: -552.33%
GF Value™: $3.57 vs. price of $9.74 (172.7% above fair value)
GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the IMTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Immatics NV Business Description

Industry Healthcare Biotechnology

Comparable Companies INVA PGEN VIR DMRA INBX ANAB GHRS MBX BHVN ARDX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges 4A3:Germany

Address Paul-Ehrlich-Strasse 15, Tubingen, BW, DEU, 72076

Website https://www.immatics.com

Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

60GF Score

Get the complete analysis for IMTX

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.74

Price

$3.57

GF Value

View IMTX Analysis

See OCF Margin % data for all stocks →